SCHEMBL1262250

SCHEMBL1262250

CC(=O)C(C)C(C)CCC=O

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.31
ALOX15 P16050 1/20 0.31
ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16052611 0.80 ALOX15 (0.31) TSHRALOX15
SCHEMBL1262249 0.76 ALDH1A1 (0.31) ALDH1A1
SCHEMBL1260681 0.76
SCHEMBL1260754 0.76 ALDH1A1 (0.42) TSHRALOX15ALDH1A1
SCHEMBL16155368 0.75 CYP2D6 (0.38) TSHRALOX15
Acetone SCHEMBL6251480 0.73 CA1 (0.39) TSHRALOX15ALDH1A1
SCHEMBL13917035 0.73 HPGD (0.35) TSHRALOX15ALDH1A1
SCHEMBL1782548 0.73 METAP1 (0.41) TSHRALDH1A1
SCHEMBL27671361 0.72 ALDH1A1 (0.32) TSHRALDH1A1
SCHEMBL1783577 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7880038-B2 complexing a tungsten boride and molybdenum boride, a phosphate compound, Mo and W metal, hydrogen peroxide and an amine oxide to form a catalyst, reacting an olefin with H2O2 in the pH 0 to 2 or more, in presence of above catalyst to produce carbonyl compounds by oxidative breaking of C-C bond of olefin SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-02-01 US disclosed
EP-1618953-B1 USE OF A METAL CATALYST SUMITOMO CHEMICAL CO (JP) 2010-12-08 EP disclosed
US-20060211891-A1 Metal catalyst and its use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-21 US disclosed
EP-1618953-A1 METAL CATALYST AND ITS USE Sumitomo Chemical Company, Limited (JP) 2006-01-25 EP disclosed
EP-1188735-B1 Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL CO (JP) 2005-07-27 EP disclosed
US-20040152592-A1 Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL COMPANY, LIMTED 2004-08-05 US disclosed
WO-2003066559-A1 PROCESS FOR PRODUCTION OF ALDEHYDES AND KETONES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-08-14 WO disclosed
EP-1188735-A1 Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-20 EP disclosed
US-20020025906-A1 Process for producing carbonyl or hydroxy compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060211891-A1 Metal catalyst and its use SOD1, NOX4, MVD TSHR 2499/4885ALOX15 2661/4885ALDH1A1 4428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.